Endothelium, Nitric Oxide and AtherosclerosisISBN: 978-0-87993-436-1
Hardcover
320 pages
June 1999, Wiley-Blackwell
|
Julio A. Panza and Richard O. Cannon.
Contributors.
Part I: The Endothelium and the Biology of Nitric Oxide.
Chapter 1: Discovery of Endothelium-Derived Relaxing Factor and Its Identification as Nitric Oxide.
Robert F. Furchgott.
Chapter 2: Discovery of Biological Roles of Nitric Oxide in the Cardiovascular System.
Salvador Moncada and E. Annie Higgs.
Chapter 3: Molecular Mechanisms of Intracellular Endothelium Nitric Oxide Regulation.
William E. Downey and Thomas Michel.
Chapter 4: Cardiovascular Effects of Nitric Oxide: Lessons Learned from Endothelial Nitric Oxide Synthase Knockout Mice.
Paul L. Huang, Robert Gyurko, and Lin Zhang.
Chapter 5: Nitric Oxide Signaling Mediating Relaxation of Vascular Smooth Muscle.
Richard A. Cohen.
Chapter 6: Hemoglobin-Bound Nitric Oxide Participates in the Mammalian Respiratory Cycle.
Timothy J. McMahon and Jonathan S. Stamler.
Chapter 7: Hormonal Regulation of Endothelium-Derived Factors.
Virginia M. Miller.
.
Part II: Basic Mechanisms of Endothelial Dysfunction.
Chapter 8: Endothelial Dysfunction and Vascular Disease.
Paul M. Vanhoutte.
Chapter 9: Endothelium-Derived Constricting Factors and Endothelial Dysfunction.
Frank T. Ruschitzka, Georg Noll, and Thomas F. Lüscher.
Chapter 10: Endothelial Nitric Oxide and Vascular Inflammation.
James K. Liao.
Chapter 11: Vascular Oxidant Stress and Nitric Oxide Bioactivity.
A. Maziar Zafari, David G. Harrison, and Kathy K. Griendling.
.
Part III: Clinical Studies of Endothelial Function and Dysfunction.
Chapter 12: Endothelium, Nitric Oxide, and Hypertension.
Julio A. Panza.
Chapter 13: Nitric Oxide Availability in Hypercholesterolemia.
Robert A. Vogel.
Chapter 14: Nitric Oxide Activity in the Human Coronary Circulation.
Arshed A. Quyyumi.
Chapter 15: Endothelial Vasodilator Dysfunction in Chronic Heart Failure.
Helmut Drexler and Burkhard Hornig.
Chapter 16: In Vitro Studies of the Human Microcirculation in Cardiovascular Disorders.
Anthony M. Heagerty.
.
Part IV: Therapeutic Strategies to Improve Endothelial Dysfunction.
Chapter 17: Endothelium as a Target of the Risk Factors in Cardiovascular Disease.
Scott Kinlay, Andrew P. Selwyn, and Peter Ganz.
Chapter 18: Oxidant Stress and Endothelial Function in Patients with Risk Factors for Atherosclerosis.
Mark A. Creager.
Chapter 19: Endothelium-Derived Nitric Oxide: An Antiatherogenic Molecule.
Shanthi Adimoolam and John P. Cooke.
Chapter 20: Hormone Therapy and Nitric Oxide Bioactivity in Postmenopausal Women.
Richard O. Cannon III.
Chapter 21: Clinical Trials Using Angiotensin-Converting Enzyme Inhibition to Alter Endothelial Dysfunction in Coronary Patients.
G. B. John Mancini.
Chapter 22: Nitrate Therapy in Cardiovascular Disease.
Jonathan Abrams.
Index